GO:1905605 positive regulation of blood-brain barrier permeability: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905605 describes any biological process that increases the permeability of the blood-brain barrier (BBB), allowing greater passage of macromolecules, small molecules, and ions into and out of the brain.
• BBB permeability is dynamically regulated by brain temperature, energy homeostasis, and neurovascular plasticity, not merely by passive diffusion.
• Endothelial signaling pathways such as AKT, TAK1, and HMGB1/TLR4 directly modulate tight junction integrity and BBB opening.
• Focused ultrasound with microbubbles is an established experimental method to transiently and safely increase BBB permeability for drug and mRNA delivery.
• Dysregulation of BBB permeability contributes to glioblastoma progression, subarachnoid hemorrhage injury, and altered drug delivery in neurological disease.
• CRISPR knockout, knock-in, and overexpression models are essential to causally test genes that regulate BBB permeability in endothelial and neuronal compartments.
Description
The blood-brain barrier (BBB) is a highly specialized neurovascular interface that controls the exchange of substances between the bloodstream and the brain parenchyma. The Gene Ontology term GO:1905605, positive regulation of blood-brain barrier permeability, refers to any process that increases the quality of the BBB that allows for controlled passage of substances such as macromolecules, small molecules, and ions into and out of the brain. This term is distinct from general BBB maintenance because it specifically captures events that enhance permeability, whether transiently for drug delivery or pathologically in disease. Understanding GO:1905605 is critical for researchers in neurobiology, drug delivery, and neuroinflammation because the BBB remains the principal obstacle to brain-targeted therapeutics. Experimental evidence shows that BBB permeability is not static; it depends on brain temperature, endothelial signaling, and neurovascular plasticity. For example, focused ultrasound combined with microbubbles can transiently open the BBB to enhance lipid nanoparticle-mediated mRNA delivery to the brain. Conversely, pathological increases in BBB permeability occur in subarachnoid hemorrhage and glioblastoma, where endothelial TAK1 and HMGB1/TLR4 signaling disrupt tight junctions. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:1905605, its molecular players, disease relevance, and CRISPR-based methods for functional interrogation.
positive regulation of blood-brain barrier permeability At A Glance
| GO ID | GO:1905605 |
|---|---|
| GO term | positive regulation of blood-brain barrier permeability |
| Ontology | biological_process |
| Synonym | activation of maintenance of permeability of BBB; positive regulation of BBB permeability; upregulation of blood-brain barrier permeability; up-regulation of blood/brain barrier permeability |
| Major function | Increases the controlled passage of macromolecules, small molecules, and ions across the blood-brain barrier into and out of the brain |
| Related cellular component | Endothelial tight junctions, basement membrane, astrocyte end-feet, pericytes |
| Key signaling pathways | AKT, TAK1, HMGB1/TLR4, ZO-1 downregulation |
| Physiological modulators | Brain temperature, energy homeostasis, neurovascular plasticity |
| Experimental induction | Focused ultrasound with microbubbles |
What Is GO:1905605?
GO:1905605 is a biological process term defined as any process that increases blood-brain barrier permeability, the quality of the blood-brain barrier that allows for a controlled passage of substances (e.g. macromolecules, small molecules, ions) into and out of the brain. In other words, it encompasses molecular and cellular events that actively enhance the leakiness or transport capacity of the BBB, as opposed to processes that maintain or restore barrier integrity. This term is a positive regulation child of blood-brain barrier permeability regulation and is relevant to both physiological states, such as temperature-dependent changes, and pathological conditions, such as neuroinflammation and tumor progression.
Why Is positive regulation of blood-brain barrier permeability Important in Cell Biology?
GO:1905605 is important because the blood-brain barrier is the primary gatekeeper of the central nervous system, and its permeability must be tightly regulated to allow nutrient and drug entry while preventing neurotoxic insults. The ability to positively regulate BBB permeability is a double-edged sword: transient opening enables delivery of large molecules such as mRNA-loaded lipid nanoparticles to the brain, whereas uncontrolled permeability contributes to edema, neuroinflammation, and tumor invasion in diseases like glioblastoma and subarachnoid hemorrhage. Moreover, BBB permeability is influenced by systemic factors including brain temperature and energy balance, linking this GO term to broader neurovascular and metabolic research. Therefore, understanding the molecular mechanisms that increase BBB permeability is essential for developing targeted therapeutics and for interpreting disease-associated barrier dysfunction.
• Enables brain delivery of macromolecular drugs, mRNA, and nanoparticles via transient BBB opening.
• Contributes to edema and neuronal injury after subarachnoid hemorrhage through TAK1-mediated pyroptosis.
• Is modulated by endothelial AKT signaling and neurogranin, revealing novel therapeutic targets.
• Is affected by hypoxia and cell-specific BBB regulation in health and disease.
• Depends on brain temperature, linking thermal physiology to barrier function.
• Influences drug delivery outcomes and is a focus of neuropharmacology.
• Is pathologically increased in glioblastoma via HMGB1/TLR4-mediated ZO-1 downregulation.
• Is interconnected with energy homeostasis and neurovascular plasticity.
• Provides a mechanistic basis for CRISPR screens targeting endothelial barrier genes.
• Serves as a biomarker and therapeutic target in neuroinflammatory and neurodegenerative conditions.
What Happens During positive regulation of blood-brain barrier permeability?
Initiation by physiological or pathological stimuli
In simple terms: Something triggers the barrier to become leakier.
Positive regulation of BBB permeability can be initiated by diverse stimuli, including focused ultrasound with microbubbles, changes in brain temperature, or pathological signals such as hypoxia and neuroinflammation. For instance, focused ultrasound/microbubbles-assisted BBB opening is used experimentally to enhance lipid nanoparticle-mediated mRNA delivery to the brain. Brain temperature elevation also increases BBB permeability, indicating that thermal stimuli can initiate barrier opening. In disease, subarachnoid hemorrhage activates TAK1 signaling in neurons, which indirectly promotes BBB permeability through pyroptosis-related mechanisms.
Endothelial signaling and tight junction modulation
In simple terms: Cells lining the blood vessels change their connections to let substances pass.
The BBB is primarily formed by brain endothelial cells joined by tight junctions. Positive regulation of permeability often involves modulation of tight junction proteins such as ZO-1. In glioblastoma, programmed cell death 10 increases BBB permeability through HMGB1/TLR4-mediated downregulation of endothelial ZO-1. Endothelial neurogranin regulates BBB permeability via modulation of the AKT pathway, demonstrating that intracellular signaling cascades in endothelial cells directly control barrier function. These molecular changes reduce tight junction integrity, allowing paracellular and transcellular transport.
Cellular and structural consequences
In simple terms: The barrier opens, allowing molecules to move in and out of the brain.
Once tight junctions are modulated, the BBB becomes more permissive to macromolecules, small molecules, and ions. This can be transient, as in focused ultrasound-mediated opening, or sustained, as in tumor-associated BBB disruption. The structural consequences include increased vesicular transport, altered basement membrane interactions, and changes in astrocyte end-feet and pericyte coverage, although the exact contributions vary by context. Energy homeostasis and neurovascular plasticity further influence these structural changes.
Resolution or persistence
In simple terms: The barrier may close again or stay leaky depending on the situation.
Positive regulation of BBB permeability can be reversible or persistent. Focused ultrasound-induced opening is typically transient and resolves within hours, which is advantageous for drug delivery. In contrast, pathological conditions such as glioblastoma and subarachnoid hemorrhage may lead to sustained permeability, contributing to edema and further injury. The balance between opening and closure is influenced by factors like brain temperature and energy status, which can prolong or mitigate barrier dysfunction.
Key Genes Involved in GO:1905605 positive regulation of blood-brain barrier permeability
The following genes and proteins have been experimentally implicated in positive regulation of blood-brain barrier permeability, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TAK1 (MAP3K7) | Mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage, indirectly increasing BBB permeability | Target for neuroinflammation and BBB disruption after hemorrhage |
| Neurogranin (NRGN) | Endothelial neurogranin regulates BBB permeability via AKT pathway modulation | Potential endothelial-specific target for barrier modulation |
| AKT1 | Signaling pathway modulated by neurogranin to regulate BBB permeability | Central kinase in endothelial barrier regulation |
| HMGB1 | Increases BBB permeability through TLR4-mediated downregulation of endothelial ZO-1 in glioblastoma | Therapeutic target in brain tumor-associated edema |
| TLR4 | Mediates HMGB1 signaling to downregulate ZO-1 and increase BBB permeability | Innate immune receptor linking inflammation to barrier opening |
| ZO-1 (TJP1) | Tight junction protein whose downregulation increases BBB permeability | Key effector of barrier integrity |
| PDCD10 (CCM3) | Programmed cell death 10 increases BBB permeability through HMGB1/TLR4 pathway | Associated with cerebral cavernous malformation and tumor permeability |
| VEGFA | Hypoxia-inducible factor target implicated in BBB regulation under hypoxia | Angiogenic and permeability factor in hypoxia |
| HIF1A | Mediates hypoxia-induced BBB regulation | Transcription factor linking oxygen sensing to barrier function |
| AQP4 | Astrocytic water channel contributing to BBB permeability and edema | Target for edema management |
| CLDN5 | Tight junction claudin family member; modulation affects BBB permeability | Core structural component of tight junctions |
| OCLN | Occludin tight junction protein; changes correlate with permeability | Marker of barrier integrity |
| TJP1 | Tight junction protein 1 (ZO-1); downregulation increases permeability | Central to tight junction assembly |
| NFKB1 | Inflammatory transcription factor downstream of TLR4 that can promote BBB permeability | Links inflammation to barrier opening |
| CASP1 | Pyroptosis effector downstream of TAK1 in subarachnoid hemorrhage | Mediator of neuronal injury and BBB disruption |
| GSDMD | Gasdermin D executes pyroptosis and may contribute to BBB permeability | Pyroptosis marker in neuroinflammation |
| IL1B | Pro-inflammatory cytokine released during pyroptosis, promoting BBB permeability | Cytokine link between inflammation and barrier opening |
| TNF | Pro-inflammatory cytokine that can increase BBB permeability | Inflammatory mediator in neurovascular disease |
How Is positive regulation of blood-brain barrier permeability Regulated?
Positive regulation of blood-brain barrier permeability is controlled at multiple levels. At the signaling level, the AKT pathway in endothelial cells is modulated by neurogranin to influence barrier function. In pathological states, TAK1 mediates neuronal pyroptosis and indirectly increases BBB permeability after subarachnoid hemorrhage. The HMGB1/TLR4 axis downregulates endothelial ZO-1, leading to increased permeability in glioblastoma. Physiologically, brain temperature directly affects BBB permeability, with higher temperatures associated with increased permeability. Energy homeostasis and neurovascular plasticity also regulate BBB function, integrating systemic metabolic signals with barrier properties. Hypoxia is another key regulator, with cell-specific responses in endothelial cells, astrocytes, and pericytes. These diverse regulatory inputs converge on tight junction integrity and transport mechanisms, making GO:1905605 a highly context-dependent process.
positive regulation of blood-brain barrier permeability and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDCD10 | Glioblastoma, increased BBB permeability via HMGB1/TLR4/ZO-1 | U87 or patient-derived glioblastoma xenograft with PDCD10 knockout |
| TAK1 (MAP3K7) | Subarachnoid hemorrhage, neuronal pyroptosis and BBB disruption | Mouse subarachnoid hemorrhage model with endothelial or neuronal TAK1 knockout |
| NRGN | Endothelial barrier regulation via AKT | Brain endothelial cell culture with NRGN knockout or overexpression |
| HIF1A | Hypoxia-induced BBB permeability | Hypoxia-exposed endothelial cells with HIF1A knockdown |
| HMGB1 | Glioblastoma-associated BBB opening | Intracranial tumor model with HMGB1 neutralization or knockout |
Glioblastoma and brain tumor edema
In glioblastoma, programmed cell death 10 increases BBB permeability through HMGB1/TLR4-mediated downregulation of endothelial ZO-1. This contributes to tumor-associated edema and may facilitate tumor cell infiltration. Targeting the HMGB1/TLR4/ZO-1 axis could reduce pathological BBB permeability while preserving normal barrier function.
Subarachnoid hemorrhage and early brain injury
TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage, which is associated with increased BBB permeability. This pathway involves inflammasome activation and release of pro-inflammatory cytokines such as IL1B, leading to barrier disruption. Inhibiting TAK1 or downstream pyroptosis effectors may protect against BBB breakdown and improve outcomes.
Hypoxia and neurovascular disease
Hypoxia regulates BBB permeability in a cell-specific manner, affecting endothelial cells, astrocytes, and pericytes. Hypoxia-inducible factors such as HIF1A drive expression of permeability factors like VEGFA, contributing to barrier dysfunction in stroke and other hypoxic-ischemic conditions. Understanding these mechanisms is critical for developing therapies that normalize BBB permeability.
Drug delivery and therapeutic opening
Transient positive regulation of BBB permeability is exploited for drug delivery. Focused ultrasound with microbubbles safely opens the BBB to enhance lipid nanoparticle-mediated mRNA delivery to the brain. This approach is being explored for treating neurological disorders, but requires precise control to avoid excessive permeability and neurotoxicity. Feelings and psychological states may also influence BBB permeability and drug delivery outcomes, highlighting the need for comprehensive models.
From positive regulation of blood-brain barrier permeability-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does endothelial neurogranin causally regulate BBB permeability via AKT? | Endothelial-specific NRGN knockout mouse or brain endothelial cells with CRISPR KO |
| Does TAK1 in neurons drive BBB permeability after subarachnoid hemorrhage? | Neuron-specific TAK1 knockout mouse subjected to subarachnoid hemorrhage |
| Can focused ultrasound-mediated BBB opening enhance mRNA delivery? | Wild-type mouse with focused ultrasound and microbubbles, followed by LNP-mRNA administration |
| Does PDCD10 increase BBB permeability through HMGB1/TLR4? | PDCD10 knockout glioblastoma cells or xenografts with ZO-1 readout |
| How does brain temperature affect BBB permeability? | Temperature-controlled animal model with tracer leakage assays |
| What is the role of energy homeostasis in BBB regulation? | Diet-induced obesity or fasting mouse models with BBB permeability assessment |
How to Study the positive regulation of blood-brain barrier permeability Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Evans blue extravasation | BBB permeability to albumin-bound dye | In vivo quantification of barrier opening |
| TEER | Transendothelial electrical resistance | In vitro barrier integrity in endothelial monolayers |
| Immunofluorescence for ZO-1 | Tight junction protein localization and expression | Assessment of barrier disruption in tissue |
| Western blot for tight junction proteins | Protein levels of ZO-1, occludin, claudins | Molecular mechanism studies |
| Focused ultrasound with microbubbles | Controlled BBB opening | Drug and mRNA delivery to brain |
| MRI with contrast | In vivo BBB leakage | Preclinical and clinical imaging |
| Two-photon microscopy | Real-time vascular permeability | Live imaging in animal models |
| CRISPR knockout in endothelial cells | Causal gene function | Target validation for BBB regulators |
Tracer leakage assays
Evans blue or fluorescent tracer extravasation is commonly used to quantify BBB permeability in animal models. These assays measure the amount of tracer that crosses from blood into brain parenchyma, providing a direct readout of GO:1905605 activity.
Tight junction protein analysis
Western blotting, immunofluorescence, and qPCR for tight junction proteins such as ZO-1, occludin, and claudins are used to assess molecular changes underlying increased permeability. Downregulation of ZO-1 is a hallmark of HMGB1/TLR4-mediated BBB opening.
In vitro BBB models
Brain endothelial cell monolayers and co-culture models with astrocytes and pericytes are used to study barrier function in vitro. Transendothelial electrical resistance (TEER) and permeability to fluorescent dextrans are standard measurements.
Imaging and functional assays
Magnetic resonance imaging (MRI) with contrast agents, two-photon microscopy, and focused ultrasound targeting are used to visualize and quantify BBB opening in vivo. These methods are essential for translational studies of drug delivery and disease progression.
How CRISPR Can Be Used to Study GO:1905605 positive regulation of blood-brain barrier permeability
Knockout
CRISPR knockout of candidate genes such as NRGN, PDCD10, or TAK1 in endothelial or neuronal cells can determine whether they are required for positive regulation of BBB permeability. For example, PDCD10 knockout in glioblastoma cells reduces HMGB1/TLR4-mediated ZO-1 downregulation and permeability. Endothelial NRGN knockout alters AKT signaling and barrier function.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to disable specific phosphorylation sites in signaling proteins like AKT or TAK1. This allows precise dissection of signaling events that increase BBB permeability without confounding effects of complete protein loss.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous loci (e.g., ZO-1-GFP) enables real-time tracking of tight junction dynamics during BBB opening. Knock-in of human disease mutations into mouse genes can model familial forms of neurovascular disease.
Overexpression
Overexpression of genes such as HMGB1 or PDCD10 in brain endothelial cells or tumor models can drive increased BBB permeability, validating their sufficiency. Conversely, overexpression of dominant-negative AKT can block neurogranin-mediated permeability changes.
How EDITGENE Supports positive regulation of blood-brain barrier permeability Research
Researchers studying positive regulation of blood-brain barrier permeability-related genes often need to determine whether a candidate gene is causally involved in barrier opening or maintenance. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional interrogation of GO:1905605 mechanisms.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of blood-brain barrier permeability research.
Frequently Asked Questions About positive regulation of blood-brain barrier permeability
What is GO:1905605?
GO:1905605 is a Gene Ontology biological process term for positive regulation of blood-brain barrier permeability, defined as any process that increases the controlled passage of substances such as macromolecules, small molecules, and ions into and out of the brain.
What genes are involved in positive regulation of blood-brain barrier permeability?
Key genes include NRGN, AKT1, TAK1 (MAP3K7), PDCD10, HMGB1, TLR4, ZO-1 (TJP1), and HIF1A, among others.
How is blood-brain barrier permeability increased experimentally?
Focused ultrasound with microbubbles is a well-established method to transiently open the BBB, enhancing delivery of lipid nanoparticles and mRNA to the brain.
What diseases involve increased BBB permeability?
Glioblastoma, subarachnoid hemorrhage, hypoxia-ischemic injury, and neuroinflammatory conditions are associated with increased BBB permeability.
Does brain temperature affect BBB permeability?
Yes, BBB permeability depends on brain temperature, with higher temperatures associated with increased permeability.
What is the role of ZO-1 in BBB permeability?
ZO-1 is a tight junction protein; its downregulation, for example via HMGB1/TLR4 signaling, increases BBB permeability.
How does neurogranin regulate BBB permeability?
Endothelial neurogranin regulates BBB permeability via modulation of the AKT pathway.
Can CRISPR be used to study BBB permeability genes?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to causally test genes involved in BBB permeability regulation.
What is the link between energy homeostasis and BBB permeability?
Energy homeostasis and neurovascular plasticity interact to influence BBB function, integrating metabolic signals with barrier properties.
How does subarachnoid hemorrhage increase BBB permeability?
TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage, which is associated with increased BBB permeability.
Conclusion
GO:1905605, positive regulation of blood-brain barrier permeability, is a critical biological process that governs the controlled opening of the BBB to macromolecules, small molecules, and ions. Its mechanisms involve endothelial signaling pathways such as AKT and TAK1, tight junction modulation, and responses to physiological factors like brain temperature and energy homeostasis. Dysregulation of this process contributes to glioblastoma, subarachnoid hemorrhage, and other neurovascular diseases, while controlled activation is exploited for drug and mRNA delivery. CRISPR-based models are indispensable for dissecting the causal roles of specific genes in this process. EDITGENE provides comprehensive services to support such research, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Ogawa K et al.. 2022. Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain.. J Control Release 348:34-41 PMID: 35640764
- 2. Xu P et al.. 2021. TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage.. J Neuroinflammation 18(1):188 PMID: 34461942
- 3. Akande AO et al.. 2025. Endothelial Neurogranin Regulates Blood-Brain Barrier Permeability via Modulation of the AKT Pathway.. Mol Neurobiol 62(4):3991-4007 PMID: 39367201
- 4. Engelhardt S et al.. 2014. Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.. Br J Pharmacol 171(5):1210-30 PMID: 24641185
- 5. Kiyatkin EA et al.. 2009. Permeability of the blood-brain barrier depends on brain temperature.. Neuroscience 161(3):926-39 PMID: 19362131
- 6. Ocab O et al.. 2025. Influence of feelings on the blood-brain barrier (BBB) and drug delivery.. Prog Brain Res 293:203-242 PMID: 40441783
- 7. Wu S et al.. 2023. Programmed cell death 10 increased blood-brain barrier permeability through HMGB1/TLR4 mediated downregulation of endothelial ZO-1 in glioblastoma.. Cell Signal 107:110683 PMID: 37075875
- 8. Chen B et al.. 2024. The interactions between energy homeostasis and neurovascular plasticity.. Nat Rev Endocrinol 20(12):749-759 PMID: 39054359
